Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $716,109 | 261 | 78.5% |
| Consulting Fee | $65,093 | 31 | 7.1% |
| Food and Beverage | $60,082 | 1,698 | 6.6% |
| Travel and Lodging | $53,436 | 219 | 5.9% |
| Honoraria | $16,107 | 9 | 1.8% |
| Education | $979.54 | 47 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $550,088 | 640 | $0 (2024) |
| Galderma Laboratories, L.P. | $125,265 | 242 | $0 (2024) |
| UCB, Inc. | $32,908 | 85 | $0 (2024) |
| Dermavant Sciences, Inc. | $32,891 | 81 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $22,204 | 73 | $0 (2024) |
| Incyte Corporation | $21,010 | 53 | $0 (2024) |
| PFIZER INC. | $15,589 | 145 | $0 (2024) |
| DERMIRA, INC. | $15,341 | 22 | $0 (2020) |
| Allergan Inc. | $13,918 | 33 | $0 (2017) |
| Promius Pharma LLC | $13,724 | 44 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204,199 | 378 | ABBVIE INC. ($118,640) |
| 2023 | $182,420 | 333 | ABBVIE INC. ($99,095) |
| 2022 | $148,537 | 292 | ABBVIE INC. ($115,457) |
| 2021 | $27,050 | 171 | AbbVie Inc. ($16,189) |
| 2020 | $31,964 | 124 | AbbVie Inc. ($15,872) |
| 2019 | $101,337 | 269 | AbbVie, Inc. ($56,788) |
| 2018 | $106,273 | 363 | AbbVie, Inc. ($66,244) |
| 2017 | $110,027 | 335 | AbbVie, Inc. ($61,803) |
All Payment Transactions
2,265 individual payment records from CMS Open Payments — Page 1 of 91
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 12/23/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,950.00 | General |
| Category: Inflammation & Immunology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Inflammation & Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $6.47 | General |
| 12/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $5.73 | General |
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Immunology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $70.22 | General |
| Category: Inflammation & Immunology | ||||||
| 12/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.69 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $1,031.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $120.01 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 640 | 999 | $192,140 | $70,671 |
| 2022 | 9 | 757 | 1,077 | $201,715 | $76,525 |
| 2021 | 12 | 845 | 1,360 | $195,339 | $78,619 |
| 2020 | 13 | 741 | 1,184 | $154,058 | $54,172 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 250 | $42,500 | $19,461 | 45.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 82 | 126 | $47,250 | $13,566 | 28.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 100 | 253 | $44,275 | $12,995 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $20,710 | $11,556 | 55.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 94 | 114 | $19,950 | $7,202 | 36.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 52 | 114 | $13,680 | $3,949 | 28.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 13 | $2,275 | $1,146 | 50.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 18 | 20 | $1,500 | $796.36 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 263 | $43,650 | $21,150 | 48.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 90 | 123 | $46,125 | $13,788 | 29.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 124 | 245 | $42,875 | $12,956 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $19,520 | $10,859 | 55.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 122 | 142 | $24,850 | $9,699 | 39.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 59 | 102 | $12,240 | $3,691 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 54 | $8,130 | $2,248 | 27.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 20 | 32 | $2,400 | $1,097 | 45.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $1,925 | $1,037 | 53.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 113 | 272 | $47,600 | $14,459 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 163 | $22,005 | $13,338 | 60.6% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 68 | 104 | $39,000 | $12,073 | 31.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 113 | 138 | $24,150 | $9,495 | 39.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 180 | $21,630 | $9,149 | 42.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 61 | 61 | $10,675 | $6,396 | 59.9% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 64 | 123 | $12,300 | $4,602 | 37.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 61 | 61 | $7,625 | $3,966 | 52.0% |
About Dr. Christopher Obeime, MD
Dr. Christopher Obeime, MD is a Specialist healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659480697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Obeime, MD has received a total of $911,807 in payments from pharmaceutical and medical device companies, with $204,199 received in 2024. These payments were reported across 2,265 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($716,109).
As a Medicare-enrolled provider, Obeime has provided services to 2,983 Medicare beneficiaries, totaling 4,620 services with total Medicare billing of $279,987. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Indianapolis, IN
- Active Since 08/30/2006
- Last Updated 07/01/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659480697
Products in Payments
- RINVOQ (Biological) $230,530
- Humira (Biological) $108,903
- SKYRIZI (Biological) $108,538
- AKLIEF (Drug) $69,197
- Skyrizi (Biological) $34,870
- VTAMA (Drug) $32,891
- EPIDUO FORTE (Drug) $29,708
- Bimzelx (Biological) $29,633
- HUMIRA (Biological) $22,159
- OPZELURA (Drug) $18,757
- DUPIXENT DUPILUMAB INJECTION (Biological) $16,749
- QBREXZA (Drug) $15,162
- CIBINQO (Drug) $12,977
- Promiseb Complete (Device) $6,490
- Seysara (Drug) $6,145
- ACZONE (Drug) $6,089
- TWYNEO (Drug) $5,981
- DUPIXENT (Biological) $5,609
- SEYSARA (Drug) $5,391
- DUPIXENT (Drug) $5,083
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Indianapolis
Dr. David Muram, Md, MD
Specialist — Payments: $570,000
Brian Mullis, Md, MD
Specialist — Payments: $547,817
Dr. Bruce Van Natta, Md, MD
Specialist — Payments: $425,360
Joachim Wernicke, Md, MD
Specialist — Payments: $412,683
Eromonsele Idahosa, Md, MD
Specialist — Payments: $122,569
Dr. Dmitry Arbuck, M.d, M.D
Specialist — Payments: $49,577